| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.915 | 0.002 | 0.915 | DNA synthesis inhibitor | 0.546 0.01 CHEMBL185 0.369 0.026 CHEMBL219497 0.295 0.045 CHEMBL3544570 0.307 0.041 CHEMBL3544571 | ||
| 0.769 | 0.002 | 0.769 | Cytidine deaminase inhibitor | 0.261 0.027 CHEMBL185 0.161 0.068 CHEMBL219497 | ||
| 0.758 | 0.001 | 0.758 | Thymidine kinase inhibitor | 0.087 0.008 CHEMBL185 0.085 0.008 CHEMBL219497 | ||
| 0.745 | 0.001 | 0.745 | Thymidine phosphorylase inhibitor | 0.205 0.002 CHEMBL185 0.038 0.007 CHEMBL219497 | ||
| 0.728 | 0.001 | 0.728 | Antimetabolite | 0.244 0.007 CHEMBL185 0.101 0.016 CHEMBL219497 0.112 0.015 CHEMBL3544570 0.113 0.015 CHEMBL3544571 | ||
| 0.683 | 0 | 0.683 | Uridine phosphorylase inhibitor | 0.129 0.002 CHEMBL185 0.049 0.008 CHEMBL219497 0.025 0.022 CHEMBL3544571 | ||
| 0.672 | 0.003 | 0.672 | RNA-directed DNA polymerase inhibitor | 0.347 0.024 CHEMBL185 0.476 0.012 CHEMBL219497 0.174 0.144 CHEMBL3544570 0.223 0.071 CHEMBL3544571 | ||
| 0.613 | 0.008 | 0.613 | DNA damaging | 0.363 0.037 CHEMBL185 | ||
| 0.604 | 0.001 | 0.604 | UDP-glucose 4-epimerase inhibitor | 0.267 0.012 CHEMBL185 0.375 0.007 CHEMBL219497 0.112 0.049 CHEMBL3544570 0.166 0.024 CHEMBL3544571 | ||
| 0.572 | 0.024 | 0.572 | Antibacterial | 0.339 0.108 CHEMBL185 0.302 0.134 CHEMBL3544570 0.435 0.062 CHEMBL3544571 | ||
| 0.543 | 0.004 | 0.543 | Alkylator | 0.233 0.019 CHEMBL185 0.131 0.058 CHEMBL3544570 0.096 0.094 CHEMBL3544571 | ||
| 0.568 | 0.041 | 0.568 | Caspase 9 stimulant | 0.289 0.206 CHEMBL185 0.287 0.208 CHEMBL3544571 | ||
| 0.576 | 0.055 | 0.635 | Apoptosis agonist | 0.635 0.042 CHEMBL185 | CHEMBL185 | |
| 0.525 | 0.005 | 0.525 | DNA methylase inhibitor | |||
| 0.507 | 0.004 | 0.507 | DNA polymerase I inhibitor | 0.201 0.028 CHEMBL219497 0.125 0.064 CHEMBL3544571 | ||
| 0.503 | 0.003 | 0.503 | NADH dehydrogenase inhibitor | 0.132 0.023 CHEMBL185 0.131 0.023 CHEMBL219497 0.12 0.028 CHEMBL3544570 0.183 0.012 CHEMBL3544571 | ||
| 0.493 | 0.003 | 0.493 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.227 0.012 CHEMBL185 0.139 0.03 CHEMBL219497 0.131 0.034 CHEMBL3544570 0.22 0.013 CHEMBL3544571 | ||
| 0.466 | 0.001 | 0.466 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.034 0.008 CHEMBL185 0.045 0.004 CHEMBL219497 | ||
| 0.458 | 0.001 | 0.458 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.104 0.013 CHEMBL185 0.072 0.025 CHEMBL219497 0.057 0.038 CHEMBL3544570 0.091 0.016 CHEMBL3544571 | ||
| 0.46 | 0.006 | 0.46 | Adenylate cyclase inhibitor | 0.106 0.079 CHEMBL3544571 | ||
| 0.502 | 0.081 | 0.502 | DNA directed DNA polymerase inhibitor | |||
| 0.413 | 0.003 | 0.413 | Phosphorylase inhibitor | 0.057 0.027 CHEMBL185 | ||
| 0.455 | 0.046 | 0.466 | Immunosuppressant | 0.466 0.043 CHEMBL185 0.228 0.168 CHEMBL3544570 0.353 0.085 CHEMBL3544571 | CHEMBL185 | |
| 0.413 | 0.006 | 0.413 | Peptidyltransferase inhibitor | 0.227 0.069 CHEMBL185 0.211 0.085 CHEMBL219497 0.226 0.07 CHEMBL3544570 0.304 0.023 CHEMBL3544571 | ||
| 0.402 | 0.007 | 0.402 | Interleukin 6 antagonist | |||
| 0.402 | 0.008 | 0.402 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.199 0.073 CHEMBL3544571 | ||
| 0.38 | 0.009 | 0.38 | NOS3 expression enhancer | 0.195 0.043 CHEMBL219497 | ||
| 0.371 | 0.005 | 0.371 | DNA directed RNA polymerase inhibitor | 0.189 0.015 CHEMBL185 0.109 0.047 CHEMBL219497 | ||
| 0.371 | 0.012 | 0.371 | DNA methyltransferase I inhibitor | |||
| 0.362 | 0.003 | 0.362 | Argininosuccinate synthase inhibitor | 0.089 0.022 CHEMBL185 0.064 0.034 CHEMBL219497 0.117 0.016 CHEMBL3544570 0.183 0.009 CHEMBL3544571 | ||
| 0.359 | 0.004 | 0.359 | DNA repair enzyme inhibitor | 0.136 0.046 CHEMBL185 0.163 0.021 CHEMBL219497 0.107 0.105 CHEMBL3544571 | ||
| 0.403 | 0.049 | 0.403 | Immunostimulant | 0.21 0.114 CHEMBL3544570 0.271 0.088 CHEMBL3544571 | ||
| 0.305 | 0.001 | 0.305 | Thymidylate synthase inhibitor | 0.15 0.003 CHEMBL185 0.046 0.033 CHEMBL219497 0.043 0.037 CHEMBL3544571 | ||
| 0.291 | 0.006 | 0.291 | Phosphofructokinase-1 inhibitor | 0.086 0.038 CHEMBL185 0.067 0.05 CHEMBL219497 0.122 0.025 CHEMBL3544570 0.195 0.012 CHEMBL3544571 | ||
| 0.277 | 0.001 | 0.277 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.028 0.005 CHEMBL185 0.039 0.003 CHEMBL219497 | ||
| 0.325 | 0.058 | 0.38 | Interleukin 2 agonist | 0.243 0.127 CHEMBL3544570 0.38 0.034 CHEMBL3544571 | CHEMBL3544571 | |
| 0.333 | 0.081 | 0.333 | Vasodilator, peripheral | 0.196 0.18 CHEMBL3544570 0.325 0.085 CHEMBL3544571 | ||
| 0.26 | 0.021 | 0.485 | Alpha-N-acetylglucosaminidase inhibitor | 0.196 0.035 CHEMBL185 0.21 0.031 CHEMBL219497 0.33 0.013 CHEMBL3544570 0.485 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.241 | 0.007 | 0.241 | HIV-1 reverse transcriptase inhibitor | 0.151 0.014 CHEMBL185 | ||
| 0.307 | 0.079 | 0.598 | Immunomodulator | 0.598 0.012 CHEMBL219497 0.288 0.089 CHEMBL3544570 0.547 0.017 CHEMBL3544571 | CHEMBL219497 | |
| 0.212 | 0.024 | 0.212 | Topoisomerase I inhibitor | |||
| 0.189 | 0.009 | 0.189 | Thioredoxin inhibitor | 0.129 0.025 CHEMBL185 | ||
| 0.254 | 0.076 | 0.291 | Interleukin agonist | 0.291 0.053 CHEMBL3544571 | CHEMBL3544571 | |
| 0.181 | 0.008 | 0.265 | Carbamoyl phosphate synthetase inhibitor | 0.09 0.024 CHEMBL185 0.086 0.026 CHEMBL219497 0.265 0.005 CHEMBL3544570 0.214 0.007 CHEMBL3544571 | CHEMBL3544570 | |
| 0.201 | 0.035 | 0.201 | Hexokinase inhibitor | |||
| 0.182 | 0.018 | 0.182 | Interleukin 8 antagonist | 0.116 0.067 CHEMBL185 | ||
| 0.189 | 0.038 | 0.189 | Interleukin 1 antagonist | |||
| 0.263 | 0.116 | 0.263 | Cholesterol antagonist | 0.257 0.12 CHEMBL3544571 | ||
| 0.156 | 0.011 | 0.156 | Ribonucleotide reductase inhibitor | 0.071 0.031 CHEMBL3544570 0.062 0.035 CHEMBL3544571 | ||
| 0.22 | 0.08 | 0.229 | Cyclic AMP phosphodiesterase inhibitor | 0.204 0.09 CHEMBL185 0.229 0.075 CHEMBL219497 | CHEMBL219497 | |
| 0.161 | 0.022 | 0.161 | AMP-activated protein kinase stimulant | |||
| 0.149 | 0.016 | 0.149 | Adenosine A1 receptor antagonist | |||
| 0.151 | 0.019 | 0.151 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.149 | 0.027 | 0.285 | Adenylate kinase inhibitor | 0.111 0.052 CHEMBL185 0.102 0.064 CHEMBL219497 0.285 0.008 CHEMBL3544570 0.279 0.008 CHEMBL3544571 | CHEMBL3544570 | |
| 0.133 | 0.012 | 0.185 | Biliverdin reductase inhibitor | 0.126 0.013 CHEMBL185 0.106 0.017 CHEMBL219497 0.104 0.017 CHEMBL3544570 0.185 0.007 CHEMBL3544571 | CHEMBL3544571 | |
| 0.222 | 0.112 | 0.222 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.138 | 0.031 | 0.138 | Protein kinase C mu inhibitor | |||
| 0.12 | 0.016 | 0.12 | Ribonucleoside-diphosphate reductase inhibitor | 0.069 0.029 CHEMBL3544570 0.057 0.036 CHEMBL3544571 | ||
| 0.108 | 0.005 | 0.108 | Adenosine deaminase inhibitor | 0.047 0.033 CHEMBL3544571 | ||
| 0.14 | 0.038 | 0.147 | Mucolytic | 0.116 0.058 CHEMBL3544570 0.147 0.034 CHEMBL3544571 | CHEMBL3544571 | |
| 0.122 | 0.024 | 0.122 | Phosphodiesterase 6D inhibitor | 0.097 0.058 CHEMBL185 | ||
| 0.116 | 0.019 | 0.116 | Adenosine A3 receptor antagonist | |||
| 0.12 | 0.025 | 0.12 | Transcription factor NF kappa B stimulant | |||
| 0.112 | 0.022 | 0.112 | Adenosine A2a receptor antagonist | |||
| 0.171 | 0.088 | 0.171 | Hepatoprotectant | |||
| 0.11 | 0.026 | 0.272 | Glutamate dehydrogenase inhibitor | 0.074 0.051 CHEMBL185 0.257 0.007 CHEMBL3544570 0.272 0.006 CHEMBL3544571 | CHEMBL3544571 | |
| 0.092 | 0.01 | 0.092 | Purinergic P2Y antagonist | |||
| 0.095 | 0.017 | 0.238 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 CHEMBL185 0.047 0.043 CHEMBL219497 0.238 0.005 CHEMBL3544570 0.195 0.007 CHEMBL3544571 | CHEMBL3544570 | |
| 0.093 | 0.019 | 0.093 | Protein kinase C eta inhibitor | |||
| 0.08 | 0.007 | 0.096 | Fumarate hydratase inhibitor | 0.036 0.022 CHEMBL185 0.031 0.027 CHEMBL219497 0.047 0.014 CHEMBL3544570 0.096 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.224 | 0.153 | 0.236 | Apoptosis antagonist | 0.236 0.142 CHEMBL3544571 | CHEMBL3544571 | |
| 0.098 | 0.028 | 0.098 | Adenosine A2 receptor antagonist | |||
| 0.078 | 0.01 | 0.078 | Adenine nucleotide translocase inhibitor | |||
| 0.095 | 0.027 | 0.11 | Carbonic anhydrase VA inhibitor | 0.078 0.038 CHEMBL3544570 0.11 0.021 CHEMBL3544571 | CHEMBL3544571 | |
| 0.087 | 0.02 | 0.112 | Carbonic anhydrase VB inhibitor | 0.112 0.014 CHEMBL3544571 | CHEMBL3544571 | |
| 0.141 | 0.074 | 0.141 | MAP3K9 inhibitor | |||
| 0.113 | 0.056 | 0.133 | Expectorant | 0.097 0.072 CHEMBL3544570 0.133 0.043 CHEMBL3544571 | CHEMBL3544571 | |
| 0.102 | 0.045 | 0.248 | Triose-phosphate isomerase inhibitor | 0.111 0.038 CHEMBL185 0.088 0.063 CHEMBL219497 0.155 0.019 CHEMBL3544570 0.248 0.007 CHEMBL3544571 | CHEMBL3544571 | |
| 0.087 | 0.032 | 0.116 | Carbonic anhydrase V inhibitor | 0.072 0.041 CHEMBL3544570 0.116 0.023 CHEMBL3544571 | CHEMBL3544571 | |
| 0.061 | 0.007 | 0.061 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 CHEMBL185 0.038 0.013 CHEMBL219497 0.029 0.018 CHEMBL3544571 | ||
| 0.062 | 0.01 | 0.062 | Guanylate cyclase inhibitor | 0.04 0.033 CHEMBL3544571 | ||
| 0.052 | 0.001 | 0.052 | Purinergic P2Y2 agonist | 0.012 0.005 CHEMBL185 0.01 0.007 CHEMBL219497 | ||
| 0.056 | 0.009 | 0.056 | Purinergic P2Y2 antagonist | 0.034 0.023 CHEMBL185 | ||
| 0.052 | 0.006 | 0.052 | Adenosine kinase inhibitor | |||
| 0.057 | 0.012 | 0.057 | Phosphoglycerate kinase inhibitor | 0.04 0.02 CHEMBL3544570 0.04 0.019 CHEMBL3544571 | ||
| 0.078 | 0.033 | 0.078 | Protein kinase C beta inhibitor | |||
| 0.065 | 0.021 | 0.077 | Alpha-mannosidase inhibitor | 0.056 0.033 CHEMBL3544570 0.077 0.013 CHEMBL3544571 | CHEMBL3544571 | |
| 0.055 | 0.011 | 0.168 | Antibiotic Aminoglycoside-like | 0.033 0.031 CHEMBL219497 0.067 0.006 CHEMBL3544570 0.168 0.001 CHEMBL3544571 | CHEMBL3544571 | |
| 0.045 | 0.003 | 0.045 | Purinergic receptor agonist | |||
| 0.045 | 0.003 | 0.045 | Purinergic P2 agonist | |||
| 0.072 | 0.03 | 0.072 | Purinergic P2X1 antagonist | 0.061 0.042 CHEMBL3544571 | ||
| 0.05 | 0.01 | 0.05 | HCV NS5B polymerase inhibitor | |||
| 0.134 | 0.094 | 0.191 | Adenylate cyclase stimulant | 0.15 0.062 CHEMBL3544570 0.191 0.018 CHEMBL3544571 | CHEMBL3544571 | |
| 0.051 | 0.012 | 0.051 | RNA-directed RNA polymerase inhibitor | |||
| 0.043 | 0.006 | 0.043 | Sodium/glucose cotransporter inhibitor | |||
| 0.044 | 0.007 | 0.044 | Adenosine A1 receptor agonist | |||
| 0.039 | 0.003 | 0.039 | Purinergic P2Y agonist | |||
| 0.116 | 0.084 | 0.153 | Amylase inhibitor | 0.153 0.062 CHEMBL219497 0.149 0.064 CHEMBL3544571 | CHEMBL219497 | |
| 0.053 | 0.022 | 0.073 | Mannosidase inhibitor | 0.043 0.035 CHEMBL3544570 0.073 0.01 CHEMBL3544571 | CHEMBL3544571 | |
| 0.151 | 0.122 | 0.176 | Angiogenesis stimulant | 0.176 0.107 CHEMBL3544571 | CHEMBL3544571 | |
| 0.028 | 0 | 0.028 | Purinergic P2Y6 agonist | |||
| 0.037 | 0.009 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.05 | 0.023 | 0.057 | AICAR transformylase inhibitor | 0.052 0.02 CHEMBL185 0.054 0.018 CHEMBL219497 0.04 0.039 CHEMBL3544570 0.057 0.016 CHEMBL3544571 | CHEMBL3544571 | |
| 0.06 | 0.033 | 0.171 | Acyl-CoA dehydrogenase inhibitor | 0.1 0.016 CHEMBL3544570 0.171 0.007 CHEMBL3544571 | CHEMBL3544571 | |
| 0.049 | 0.03 | 0.081 | Glucose-6-phosphate isomerase inhibitor | 0.059 0.019 CHEMBL3544570 0.081 0.009 CHEMBL3544571 | CHEMBL3544571 | |
| 0.024 | 0.005 | 0.024 | Purinergic P2Y1 agonist | 0.018 0.008 CHEMBL3544571 | ||
| 0.098 | 0.081 | 0.098 | Protein kinase C gamma inhibitor | |||
| 0.025 | 0.01 | 0.025 | Isoleucine-tRNA ligase inhibitor | |||
| 0.052 | 0.038 | 0.052 | Protein 50S ribosomal subunit inhibitor | |||
| 0.04 | 0.028 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.018 | 0.008 | 0.018 | S-adenosyl-L-homocysteine hydrolase inhibitor | |||
| 0.019 | 0.009 | 0.019 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.028 | 0.018 | 0.028 | Purinergic P2X agonist | |||
| 0.019 | 0.01 | 0.019 | Adenosine A3 receptor agonist | |||
| 0.195 | 0.187 | 0.195 | Vasodilator, coronary | |||
| 0.118 | 0.111 | 0.118 | Acetylcholine M1 receptor antagonist | |||
| 0.015 | 0.009 | 0.015 | Adenosine A2b receptor agonist | |||
| 0.126 | 0.12 | 0.145 | Interferon gamma antagonist | 0.13 0.111 CHEMBL219497 0.145 0.084 CHEMBL3544571 | CHEMBL3544571 | |
| 0.135 | 0.13 | 0.147 | Lipocortins synthesis antagonist | 0.147 0.109 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.002 | 0.007 | Purinergic P2Y4 agonist | |||
| 0.192 | 0.188 | 0.222 | Antithrombotic | 0.222 0.151 CHEMBL3544571 | CHEMBL3544571 | |
| 0.015 | 0.014 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.021 | 0.022 | 0.118 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 CHEMBL3544570 0.118 0.002 CHEMBL3544571 | CHEMBL3544571 | |
| 0.038 | 0.039 | 0.078 | Kainate receptor agonist | 0.078 0.004 CHEMBL185 0.049 0.015 CHEMBL219497 0.05 0.014 CHEMBL3544570 0.07 0.004 CHEMBL3544571 | CHEMBL185 | |
| 0.084 | 0.089 | 0.107 | Anabolic | 0.089 0.08 CHEMBL185 0.107 0.054 CHEMBL3544571 | CHEMBL3544571 | |
| 0.11 | 0.115 | 0.153 | Cell wall synthesis inhibitor | 0.113 0.11 CHEMBL219497 0.13 0.085 CHEMBL3544570 0.153 0.063 CHEMBL3544571 | CHEMBL3544571 | |
| 0.016 | 0.022 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CHEMBL3544570 0.021 0.008 CHEMBL3544571 | CHEMBL3544571 | |
| 0.022 | 0.031 | 0.029 | Integrin alpha2beta1 antagonist | 0.029 0.014 CHEMBL185 0.026 0.019 CHEMBL3544570 | CHEMBL185 | |
| 0.046 | 0.058 | 0.051 | Glucosylceramidase inhibitor | 0.051 0.045 CHEMBL219497 | CHEMBL219497 | |
| 0.047 | 0.064 | 0.078 | Selectin antagonist | 0.078 0.038 CHEMBL3544571 | CHEMBL3544571 | |
| 0.101 | 0.119 | 0.12 | Protein kinase stimulant | 0.12 0.093 CHEMBL3544571 | CHEMBL3544571 | |
| 0.159 | 0.182 | 0.272 | Nitric-oxide synthase stimulant | 0.272 0.02 CHEMBL185 0.193 0.101 CHEMBL219497 0.185 0.117 CHEMBL3544570 0.23 0.049 CHEMBL3544571 | CHEMBL185 | |
| 0.073 | 0.098 | 0.082 | Hematopoietic | 0.082 0.066 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.041 | 0.017 | Telomerase stimulant | 0.017 0.011 CHEMBL3544571 | CHEMBL3544571 | |
| 0.026 | 0.061 | 0.038 | Integrin alpha2 antagonist | 0.038 0.024 CHEMBL185 0.036 0.027 CHEMBL3544570 | CHEMBL185 | |
| 0.02 | 0.055 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.013 CHEMBL3544571 | CHEMBL3544571 | |
| 0.024 | 0.059 | 0.06 | Toll-Like receptor 2 agonist | 0.043 0.027 CHEMBL3544570 0.06 0.02 CHEMBL3544571 | CHEMBL3544571 | |
| 0.124 | 0.161 | 0.141 | Heat shock protein 70 antagonist | 0.141 0.071 CHEMBL3544571 | CHEMBL3544571 | |
| 0.124 | 0.163 | 0.245 | Anticonvulsant | 0.245 0.059 CHEMBL185 | CHEMBL185 | |
| 0.113 | 0.157 | 0.168 | MAP kinase 3 inhibitor | 0.168 0.045 CHEMBL185 | CHEMBL185 | |
| 0.02 | 0.069 | 0.033 | DNA polymerase III inhibitor | 0.033 0.01 CHEMBL185 0.031 0.014 CHEMBL219497 | CHEMBL185 | |
| 0.052 | 0.101 | 0.137 | Phospholipase D inhibitor | 0.111 0.009 CHEMBL185 0.137 0.004 CHEMBL219497 0.069 0.056 CHEMBL3544570 0.08 0.034 CHEMBL3544571 | CHEMBL219497 | |
| 0.011 | 0.062 | 0.06 | Calcitonin gene-related peptide antagonist | 0.06 0.006 CHEMBL185 0.06 0.006 CHEMBL219497 | CHEMBL219497 | |
| 0.245 | 0.296 | 0.5 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.5 0.034 CHEMBL185 0.42 0.084 CHEMBL219497 0.334 0.169 CHEMBL3544570 0.343 0.158 CHEMBL3544571 | CHEMBL185 | |
| 0.008 | 0.067 | 0.024 | Calcitonin gene-related peptide 1 receptor antagonist | 0.024 0.006 CHEMBL185 0.021 0.008 CHEMBL219497 | CHEMBL185 | |
| 0.052 | 0.124 | 0.121 | Glycine receptor antagonist | 0.08 0.057 CHEMBL185 0.121 0.017 CHEMBL219497 0.086 0.048 CHEMBL3544570 0.089 0.044 CHEMBL3544571 | CHEMBL219497 | |
| 0.061 | 0.141 | 0.101 | Interleukin 5 antagonist | 0.101 0.04 CHEMBL185 | CHEMBL185 | |
| 0.038 | 0.119 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 CHEMBL3544571 | CHEMBL3544571 | |
| 0.074 | 0.161 | 0.139 | Aldehyde dehydrogenase inhibitor | 0.139 0.055 CHEMBL3544571 | CHEMBL3544571 | |
| 0.07 | 0.157 | 0.107 | Microtubule formation inhibitor | 0.107 0.078 CHEMBL3544570 | CHEMBL3544570 | |
| 0.007 | 0.096 | 0.09 | Arginase inhibitor | 0.09 0.005 CHEMBL3544570 0.087 0.005 CHEMBL3544571 | CHEMBL3544570 | |
| 0.117 | 0.209 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 CHEMBL185 0.134 0.101 CHEMBL219497 0.133 0.103 CHEMBL3544570 0.158 0.026 CHEMBL3544571 | CHEMBL3544571 | |
| 0.109 | 0.204 | 0.278 | Platelet antagonist | 0.169 0.126 CHEMBL3544570 0.278 0.061 CHEMBL3544571 | CHEMBL3544571 | |
| 0.042 | 0.143 | 0.074 | Lipocortins synthesis agonist | 0.074 0.017 CHEMBL219497 0.06 0.035 CHEMBL3544571 | CHEMBL219497 | |
| 0.049 | 0.155 | 0.112 | Alcohol dehydrogenase inhibitor | 0.11 0.042 CHEMBL185 0.112 0.041 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.113 | 0.021 | Thyroid hormone alpha agonist | 0.021 0.006 CHEMBL185 0.017 0.011 CHEMBL219497 | CHEMBL185 | |
| 0.054 | 0.162 | 0.098 | DNA intercalator | 0.098 0.076 CHEMBL185 | CHEMBL185 | |
| 0.028 | 0.139 | 0.081 | Androgen agonist | 0.081 0.024 CHEMBL219497 | CHEMBL219497 | |
| 0.094 | 0.208 | 0.614 | Antimitotic | 0.614 0.007 CHEMBL185 0.23 0.068 CHEMBL3544571 | CHEMBL185 | |
| 0.184 | 0.3 | 0.566 | Cyclophilin D inhibitor | 0.409 0.086 CHEMBL3544570 0.566 0.034 CHEMBL3544571 | CHEMBL3544571 | |
| 0.108 | 0.225 | 0.215 | Phospholipase C inhibitor | 0.191 0.05 CHEMBL3544570 0.215 0.036 CHEMBL3544571 | CHEMBL3544571 | |
| 0.009 | 0.132 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 CHEMBL3544571 | CHEMBL3544571 | |
| 0.014 | 0.153 | 0.053 | Adenosine A2b receptor antagonist | 0.053 0.031 CHEMBL185 | CHEMBL185 | |
| 0.043 | 0.183 | 0.116 | Keratolytic | 0.116 0.023 CHEMBL185 0.088 0.04 CHEMBL3544570 0.096 0.033 CHEMBL3544571 | CHEMBL185 | |
| 0.011 | 0.153 | 0.025 | Vanilloid 2 agonist | 0.025 0.019 CHEMBL3544571 | CHEMBL3544571 | |
| 0.08 | 0.225 | 0.302 | Anesthetic general | 0.19 0.08 CHEMBL185 0.141 0.124 CHEMBL219497 0.302 0.032 CHEMBL3544570 0.206 0.071 CHEMBL3544571 | CHEMBL3544570 | |
| 0.009 | 0.155 | 0.035 | AMPA receptor agonist | 0.035 0.025 CHEMBL185 | CHEMBL185 | |
| 0.018 | 0.175 | 0.62 | Alcohol oxidase inhibitor | 0.068 0.03 CHEMBL185 0.351 0.004 CHEMBL3544570 0.62 0.003 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.166 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.006 CHEMBL185 0.013 0.01 CHEMBL219497 | CHEMBL185 | |
| 0.015 | 0.176 | 0.238 | Aldose reductase inhibitor | 0.064 0.03 CHEMBL185 0.131 0.013 CHEMBL3544570 0.238 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.091 | 0.253 | 0.486 | Tumour necrosis factor alpha release inhibitor | 0.486 0.015 CHEMBL219497 | CHEMBL219497 | |
| 0.011 | 0.173 | 0.051 | Acid ceramidase inhibitor | 0.051 0.003 CHEMBL185 0.026 0.015 CHEMBL219497 | CHEMBL185 | |
| 0.036 | 0.201 | 0.072 | Interferon agonist | 0.072 0.067 CHEMBL3544571 | CHEMBL3544571 | |
| 0.104 | 0.27 | 0.192 | Hypoglycemic | 0.163 0.158 CHEMBL3544570 0.192 0.12 CHEMBL3544571 | CHEMBL3544571 | |
| 0.049 | 0.227 | 0.089 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.074 CHEMBL3544571 | CHEMBL3544571 | |
| 0.109 | 0.289 | 0.395 | 5 Hydroxytryptamine release stimulant | 0.199 0.122 CHEMBL185 0.395 0.047 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.195 | 0.068 | Glutamate (mGluR1) agonist | 0.068 0.004 CHEMBL185 0.028 0.011 CHEMBL3544571 | CHEMBL185 | |
| 0.01 | 0.195 | 0.053 | Thyroid hormone agonist | 0.031 0.012 CHEMBL3544570 0.053 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.016 | 0.21 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.026 CHEMBL219497 | CHEMBL219497 | |
| 0.03 | 0.225 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.069 0.061 CHEMBL185 0.086 0.028 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.199 | 0.052 | Prostacyclin agonist | 0.021 0.008 CHEMBL3544570 0.052 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.014 | 0.215 | 0.056 | Carbonic anhydrase XIV inhibitor | 0.056 0.027 CHEMBL3544571 | CHEMBL3544571 | |
| 0.026 | 0.23 | 0.126 | Dihydroorotate oxidase inhibitor | 0.126 0.004 CHEMBL185 0.069 0.018 CHEMBL219497 | CHEMBL185 | |
| 0.066 | 0.272 | 0.143 | Mannose-6-phosphate isomerase inhibitor | 0.143 0.071 CHEMBL185 | CHEMBL185 | |
| 0.021 | 0.228 | 0.268 | Histidine decarboxylase inhibitor | 0.201 0.013 CHEMBL3544570 0.268 0.008 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.217 | 0.049 | Nicotinic acid receptor 2 antagonist | 0.049 0.004 CHEMBL185 0.039 0.005 CHEMBL219497 | CHEMBL185 | |
| 0.031 | 0.241 | 0.075 | Somatostatin 1 agonist | 0.072 0.062 CHEMBL3544570 0.075 0.058 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.217 | 0.042 | HMG CoA reductase inhibitor | 0.042 0.013 CHEMBL3544571 | CHEMBL3544571 | |
| 0.023 | 0.237 | 0.092 | DNA gyrase inhibitor | 0.092 0.021 CHEMBL219497 0.066 0.041 CHEMBL3544570 | CHEMBL219497 | |
| 0.063 | 0.281 | 0.1 | Factor V inhibitor | 0.1 0.069 CHEMBL3544570 0.1 0.069 CHEMBL3544571 | CHEMBL3544571 | |
| 0.015 | 0.235 | 0.084 | Protein kinase (CK2) beta inhibitor | 0.068 0.005 CHEMBL185 0.084 0.004 CHEMBL219497 | CHEMBL219497 | |
| 0.034 | 0.262 | 0.132 | Glycine receptor agonist | 0.132 0.01 CHEMBL3544571 | CHEMBL3544571 | |
| 0.013 | 0.243 | 0.063 | Membrane dipeptidase inhibitor | 0.063 0.009 CHEMBL3544570 0.06 0.01 CHEMBL3544571 | CHEMBL3544570 | |
| 0.001 | 0.234 | 0.026 | Glutamate (mGluR6) agonist | 0.011 0.009 CHEMBL3544570 0.026 0.003 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.242 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 CHEMBL3544571 | CHEMBL3544571 | |
| 0.035 | 0.272 | 0.725 | GABA C receptor agonist | 0.208 0.019 CHEMBL185 0.195 0.021 CHEMBL219497 0.457 0.004 CHEMBL3544570 0.725 0.002 CHEMBL3544571 | CHEMBL3544571 | |
| 0.034 | 0.273 | 0.115 | Glutamate (mGluR6) antagonist | 0.062 0.061 CHEMBL185 0.078 0.026 CHEMBL3544570 0.115 0.006 CHEMBL3544571 | CHEMBL3544571 | |
| 0.008 | 0.25 | 0.049 | Nicotinic acid receptor 2 agonist | 0.049 0.014 CHEMBL185 | CHEMBL185 | |
| 0.03 | 0.272 | 0.226 | Aminopeptidase B inhibitor | 0.209 0.019 CHEMBL3544570 0.226 0.016 CHEMBL3544571 | CHEMBL3544571 | |
| 0.04 | 0.283 | 0.111 | MAP kinase 13 inhibitor | 0.111 0.066 CHEMBL185 | CHEMBL185 | |
| 0.018 | 0.265 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.255 | 0.041 | Prostaglandin F2 alpha agonist | 0.041 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.071 | 0.321 | 0.33 | Tumour necrosis factor antagonist | 0.33 0.013 CHEMBL185 0.163 0.085 CHEMBL219497 | CHEMBL185 | |
| 0.001 | 0.265 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.039 | 0.309 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.046 CHEMBL3544571 | CHEMBL3544571 | |
| 0.023 | 0.297 | 0.062 | Pregnane X receptor antagonist | 0.062 0.027 CHEMBL185 | CHEMBL185 | |
| 0.001 | 0.278 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 CHEMBL185 0.009 0.004 CHEMBL219497 | CHEMBL185 | |
| 0.068 | 0.352 | 0.128 | CF transmembrane conductance regulator agonist | 0.128 0.124 CHEMBL185 | CHEMBL185 | |
| 0.043 | 0.328 | 0.166 | Toll-Like receptor 2 antagonist | 0.129 0.069 CHEMBL3544570 0.166 0.042 CHEMBL3544571 | CHEMBL3544571 | |
| 0.014 | 0.304 | 0.187 | Catalase inhibitor | 0.075 0.051 CHEMBL185 0.187 0.018 CHEMBL3544570 0.175 0.02 CHEMBL3544571 | CHEMBL3544570 | |
| 0.042 | 0.333 | 0.109 | Nav1.1 sodium channel blocker | 0.109 0.056 CHEMBL185 | CHEMBL185 | |
| 0.049 | 0.345 | 0.111 | Glutamate release inhibitor | 0.111 0.029 CHEMBL3544571 | CHEMBL3544571 | |
| 0.02 | 0.316 | 0.164 | Carbonic anhydrase XIII inhibitor | 0.164 0.019 CHEMBL3544571 | CHEMBL3544571 | |
| 0.009 | 0.309 | 0.077 | Glutamate (mGluR3) antagonist | 0.077 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.042 | 0.35 | 0.14 | Photosensitizer | 0.14 0.038 CHEMBL3544571 | CHEMBL3544571 | |
| 0.014 | 0.323 | 0.075 | Glutamate (mGluR8) agonist | 0.045 0.016 CHEMBL3544570 0.075 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.046 | 0.356 | 0.2 | Arachidonic acid antagonist | 0.162 0.075 CHEMBL219497 0.154 0.084 CHEMBL3544570 0.2 0.033 CHEMBL3544571 | CHEMBL3544571 | |
| 0.062 | 0.373 | 0.269 | Growth hormone agonist | 0.128 0.11 CHEMBL185 0.126 0.111 CHEMBL219497 0.123 0.116 CHEMBL3544570 0.269 0.039 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.327 | 0.051 | Glutamate (mGluR3) agonist | 0.044 0.007 CHEMBL3544570 0.051 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.016 | 0.335 | 0.052 | Glutamate (mGluR8) antagonist | 0.037 0.021 CHEMBL3544570 0.052 0.008 CHEMBL3544571 | CHEMBL3544571 | |
| 0.001 | 0.324 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CHEMBL3544571 | CHEMBL3544571 | |
| 0.013 | 0.347 | 0.476 | Aconitate hydratase inhibitor | 0.052 0.035 CHEMBL185 0.048 0.043 CHEMBL219497 0.459 0.002 CHEMBL3544570 0.476 0.002 CHEMBL3544571 | CHEMBL3544571 | |
| 0.023 | 0.362 | 0.261 | Ornithine decarboxylase inhibitor | 0.141 0.014 CHEMBL3544570 0.261 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.06 | 0.402 | 0.184 | Vanilloid 1 agonist | 0.155 0.034 CHEMBL3544570 0.184 0.017 CHEMBL3544571 | CHEMBL3544571 | |
| 0.013 | 0.362 | 0.262 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 CHEMBL3544570 0.262 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.024 | 0.374 | 0.149 | Cystathionine beta-synthase inhibitor | 0.102 0.074 CHEMBL185 0.149 0.041 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.353 | 0.023 | Kainate receptor 1 antagonist | 0.023 0.014 CHEMBL3544571 | CHEMBL3544571 | |
| 0.113 | 0.466 | 0.364 | 5 Hydroxytryptamine uptake stimulant | 0.244 0.087 CHEMBL185 0.199 0.153 CHEMBL219497 0.249 0.082 CHEMBL3544570 0.364 0.022 CHEMBL3544571 | CHEMBL3544571 | |
| 0.006 | 0.36 | 0.074 | Glutamate (mGluR group I) agonist | 0.074 0.014 CHEMBL185 0.044 0.038 CHEMBL219497 | CHEMBL185 | |
| 0.006 | 0.362 | 0.059 | Nicotinic acid receptor agonist | 0.059 0.011 CHEMBL185 | CHEMBL185 | |
| 0.013 | 0.369 | 0.403 | Porphobilinogen synthase inhibitor | 0.069 0.057 CHEMBL185 0.122 0.028 CHEMBL3544570 0.403 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.36 | 0.031 | Prostaglandin agonist | 0.031 0.021 CHEMBL3544571 | CHEMBL3544571 | |
| 0.045 | 0.403 | 0.365 | Aldehyde oxidase inhibitor | 0.292 0.069 CHEMBL185 0.248 0.083 CHEMBL219497 0.15 0.139 CHEMBL3544570 0.365 0.052 CHEMBL3544571 | CHEMBL3544571 | |
| 0.009 | 0.369 | 0.084 | Acetylcholine M5 receptor agonist | 0.084 0.031 CHEMBL185 0.083 0.032 CHEMBL219497 | CHEMBL185 | |
| 0.023 | 0.388 | 0.178 | Creatine kinase inhibitor | 0.088 0.075 CHEMBL185 0.098 0.062 CHEMBL3544570 0.178 0.015 CHEMBL3544571 | CHEMBL3544571 | |
| 0.024 | 0.391 | 0.397 | Ferrochelatase inhibitor | 0.254 0.013 CHEMBL185 0.183 0.027 CHEMBL219497 0.247 0.014 CHEMBL3544570 0.397 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.039 | 0.408 | 0.18 | Spasmolytic | 0.18 0.137 CHEMBL3544571 | CHEMBL3544571 | |
| 0.034 | 0.406 | 0.073 | MDM2 inhibitor | 0.073 0.032 CHEMBL185 | CHEMBL185 | |
| 0.004 | 0.38 | 0.052 | Acetylcholine M1 receptor agonist | 0.052 0.025 CHEMBL219497 | CHEMBL219497 | |
| 0.012 | 0.398 | 0.045 | Nicotinic acid receptor 1 agonist | 0.045 0.023 CHEMBL185 | CHEMBL185 | |
| 0.024 | 0.414 | 0.085 | Carbonic anhydrase VI inhibitor | 0.085 0.052 CHEMBL3544571 | CHEMBL3544571 | |
| 0.01 | 0.4 | 0.063 | Check point kinase 1 inhibitor | 0.063 0.053 CHEMBL219497 | CHEMBL219497 | |
| 0.007 | 0.406 | 0.033 | Calcitonin receptor agonist | 0.033 0.024 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.404 | 0.044 | Geranyltranstransferase inhibitor | 0.044 0.03 CHEMBL3544571 | CHEMBL3544571 | |
| 0.01 | 0.411 | 0.043 | GABA B receptor antagonist | 0.043 0.029 CHEMBL3544571 | CHEMBL3544571 | |
| 0.015 | 0.419 | 0.183 | GABA aminotransferase inhibitor | 0.07 0.061 CHEMBL219497 0.112 0.02 CHEMBL3544570 0.183 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.036 | 0.447 | 0.429 | Peroxidase inhibitor | 0.174 0.067 CHEMBL185 0.429 0.017 CHEMBL3544570 0.419 0.018 CHEMBL3544571 | CHEMBL3544570 | |
| 0.011 | 0.425 | 0.262 | Glutamate decarboxylase inhibitor | 0.199 0.007 CHEMBL3544570 0.262 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.029 | 0.443 | 0.113 | Carbonic anhydrase III inhibitor | 0.113 0.049 CHEMBL3544571 | CHEMBL3544571 | |
| 0.03 | 0.444 | 0.108 | Nav1.4 sodium channel blocker | 0.092 0.09 CHEMBL3544570 0.108 0.064 CHEMBL3544571 | CHEMBL3544571 | |
| 0.006 | 0.421 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CHEMBL3544571 | CHEMBL3544571 | |
| 0.024 | 0.44 | 0.175 | Thrombolytic | 0.175 0.065 CHEMBL3544571 | CHEMBL3544571 | |
| 0.081 | 0.498 | 0.323 | Calcium channel activator | 0.212 0.196 CHEMBL185 0.306 0.086 CHEMBL219497 0.323 0.07 CHEMBL3544571 | CHEMBL3544571 | |
| 0.013 | 0.431 | 0.16 | Aminopeptidase I inhibitor | 0.118 0.02 CHEMBL3544570 0.16 0.011 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.424 | 0.059 | Lysine carboxypeptidase inhibitor | 0.038 0.011 CHEMBL3544570 0.059 0.006 CHEMBL3544571 | CHEMBL3544571 | |
| 0.031 | 0.454 | 0.164 | DOPA decarboxylase inhibitor | 0.108 0.061 CHEMBL185 0.111 0.057 CHEMBL3544570 0.164 0.015 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.438 | 0.11 | Phenylethanolamine N methyltransferase inhibitor | 0.11 0.003 CHEMBL219497 | CHEMBL219497 | |
| 0.019 | 0.449 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 CHEMBL185 | CHEMBL185 | |
| 0.003 | 0.435 | 0.035 | Glutamate (mGluR1a) agonist | 0.028 0.01 CHEMBL185 0.021 0.017 CHEMBL3544570 0.035 0.007 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.445 | 0.225 | Pim-1 kinase inhibitor | 0.225 0.011 CHEMBL219497 | CHEMBL219497 | |
| 0.015 | 0.45 | 0.139 | Prostaglandin F2 alpha antagonist | 0.127 0.005 CHEMBL3544570 0.139 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.017 | 0.454 | 0.089 | Histamine N-methyltransferase inhibitor | 0.089 0.056 CHEMBL3544571 | CHEMBL3544571 | |
| 0.005 | 0.445 | 0.069 | Acetylcholine muscarinic agonist | 0.069 0.027 CHEMBL219497 | CHEMBL219497 | |
| 0.001 | 0.441 | 0.032 | Carbonic anhydrase VIII inhibitor | 0.032 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.001 | 0.441 | 0.032 | Carbonic anhydrase X inhibitor | 0.032 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.018 | 0.461 | 0.282 | GABA C receptor antagonist | 0.126 0.046 CHEMBL185 0.102 0.075 CHEMBL219497 0.138 0.037 CHEMBL3544570 0.282 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.033 | 0.475 | 0.123 | Cyclooxygenase 3 inhibitor | 0.123 0.074 CHEMBL3544571 | CHEMBL3544571 | |
| 0.008 | 0.45 | 0.132 | Protein kinase (CK2) inhibitor | 0.125 0.045 CHEMBL185 0.132 0.041 CHEMBL219497 | CHEMBL219497 | |
| 0.024 | 0.467 | 0.144 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.069 CHEMBL185 0.082 0.075 CHEMBL3544570 0.144 0.027 CHEMBL3544571 | CHEMBL3544571 | |
| 0.02 | 0.467 | 0.189 | 5 Hydroxytryptamine 3A agonist | 0.189 0.018 CHEMBL185 0.126 0.051 CHEMBL219497 | CHEMBL185 | |
| 0.01 | 0.457 | 0.13 | Pim-3 kinase inhibitor | 0.098 0.048 CHEMBL185 0.13 0.026 CHEMBL219497 | CHEMBL219497 | |
| 0.037 | 0.489 | 0.291 | Succinate dehydrogenase inhibitor | 0.148 0.115 CHEMBL185 0.207 0.044 CHEMBL3544570 0.291 0.012 CHEMBL3544571 | CHEMBL3544571 | |
| 0.014 | 0.467 | 0.079 | Glutamate (mGluR7) antagonist | 0.074 0.036 CHEMBL185 0.079 0.029 CHEMBL3544571 | CHEMBL3544571 | |
| 0.028 | 0.485 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.05 CHEMBL3544571 | CHEMBL3544571 | |
| 0.023 | 0.488 | 0.121 | Cathepsin H inhibitor | 0.121 0.074 CHEMBL3544571 | CHEMBL3544571 | |
| 0.021 | 0.487 | 0.22 | GABA C receptor rho-1 antagonist | 0.107 0.053 CHEMBL185 0.09 0.078 CHEMBL219497 0.119 0.041 CHEMBL3544570 0.22 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.036 | 0.503 | 0.089 | Estrogen-related receptor beta agonist | 0.089 0.043 CHEMBL3544571 | CHEMBL3544571 | |
| 0.065 | 0.535 | 0.223 | Sodium/bile acid cotransporter inhibitor | 0.223 0.158 CHEMBL3544571 | CHEMBL3544571 | |
| 0.006 | 0.476 | 0.04 | Oxytocin agonist | 0.04 0.031 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.477 | 0.048 | Kainate receptor antagonist | 0.048 0.023 CHEMBL3544571 | CHEMBL3544571 | |
| 0.001 | 0.479 | 0.036 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.036 0.004 CHEMBL3544570 0.032 0.005 CHEMBL3544571 | CHEMBL3544570 | |
| 0.008 | 0.486 | 0.05 | Lysophosphatidic acid 3 receptor antagonist | 0.05 0.036 CHEMBL3544571 | CHEMBL3544571 | |
| 0.001 | 0.479 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 CHEMBL3544571 | CHEMBL3544571 | |
| 0.018 | 0.497 | 0.099 | Prolactin inhibitor | 0.091 0.065 CHEMBL3544570 0.099 0.057 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.49 | 0.103 | Secretase beta inhibitor | 0.103 0.017 CHEMBL185 0.075 0.042 CHEMBL219497 | CHEMBL185 | |
| 0.005 | 0.489 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.033 CHEMBL219497 | CHEMBL219497 | |
| 0.016 | 0.501 | 0.102 | MAP kinase kinase 1 inhibitor | 0.09 0.071 CHEMBL185 0.102 0.054 CHEMBL219497 0.085 0.078 CHEMBL3544571 | CHEMBL219497 | |
| 0.085 | 0.57 | 0.848 | Antiinflammatory | 0.848 0.009 CHEMBL219497 | CHEMBL219497 | |
| 0.011 | 0.5 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.01 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.492 | 0.042 | DNA gyrase subunit B inhibitor | 0.042 0.02 CHEMBL219497 | CHEMBL219497 | |
| 0.001 | 0.491 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.011 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.497 | 0.027 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.007 CHEMBL3544570 0.027 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.005 | 0.501 | 0.161 | Integrin beta6 antagonist | 0.161 0.001 CHEMBL219497 0.015 0.008 CHEMBL3544571 | CHEMBL219497 | |
| 0.017 | 0.518 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.043 CHEMBL3544571 | CHEMBL3544571 | |
| 0.034 | 0.539 | 0.166 | GABA C receptor rho-2 antagonist | 0.166 0.055 CHEMBL185 0.135 0.096 CHEMBL219497 0.153 0.07 CHEMBL3544571 | CHEMBL185 | |
| 0.007 | 0.519 | 0.057 | Dihydroorotase inhibitor | 0.057 0.018 CHEMBL185 | CHEMBL185 | |
| 0.004 | 0.52 | 0.042 | Glutamate (mGluR5) agonist | 0.042 0.038 CHEMBL219497 | CHEMBL219497 | |
| 0.003 | 0.518 | 0.033 | Kainate receptor 2 antagonist | 0.033 0.028 CHEMBL3544571 | CHEMBL3544571 | |
| 0.01 | 0.527 | 0.064 | Dopamine beta hydroxylase inhibitor | 0.047 0.038 CHEMBL185 0.064 0.011 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.519 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 CHEMBL219497 | CHEMBL219497 | |
| 0.003 | 0.525 | 0.057 | Free fatty acid receptor 1 antagonist | 0.057 0.006 CHEMBL3544571 | CHEMBL3544571 | |
| 0.017 | 0.542 | 0.173 | Nav1.6 sodium channel blocker | 0.164 0.04 CHEMBL185 0.173 0.033 CHEMBL219497 | CHEMBL219497 | |
| 0.047 | 0.575 | 0.262 | Histamine release inhibitor | 0.262 0.146 CHEMBL3544571 | CHEMBL3544571 | |
| 0.029 | 0.558 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.092 0.04 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.539 | 0.058 | Dopamine D5 agonist | 0.058 0.013 CHEMBL3544571 | CHEMBL3544571 | |
| 0.018 | 0.554 | 0.489 | TRKC antagonist | 0.489 0.006 CHEMBL219497 | CHEMBL219497 | |
| 0.004 | 0.54 | 0.074 | Alpha 1a adrenoreceptor antagonist | 0.074 0.048 CHEMBL185 | CHEMBL185 | |
| 0.029 | 0.567 | 0.099 | Glutamate (mGluR7) agonist | 0.099 0.062 CHEMBL3544571 | CHEMBL3544571 | |
| 0.042 | 0.581 | 0.431 | Superoxide dismutase inhibitor | 0.208 0.108 CHEMBL185 0.179 0.143 CHEMBL219497 0.392 0.028 CHEMBL3544570 0.431 0.022 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.552 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.046 CHEMBL219497 | CHEMBL219497 | |
| 0.033 | 0.575 | 0.136 | ATPase inhibitor | 0.136 0.128 CHEMBL185 | CHEMBL185 | |
| 0.02 | 0.563 | 0.194 | Electrolyte absorption antagonist | 0.096 0.063 CHEMBL185 0.194 0.009 CHEMBL3544570 0.13 0.029 CHEMBL3544571 | CHEMBL3544570 | |
| 0.015 | 0.561 | 0.173 | MAP kinase kinase 2 inhibitor | 0.173 0.102 CHEMBL185 | CHEMBL185 | |
| 0.005 | 0.551 | 0.096 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.096 0.049 CHEMBL219497 | CHEMBL219497 | |
| 0.024 | 0.583 | 0.115 | Carbonic anhydrase XV inhibitor | 0.115 0.051 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.564 | 0.046 | Carbonic anhydrase IV inhibitor | 0.046 0.028 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.572 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.01 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.575 | 0.041 | GABA uptake inhibitor | 0.041 0.025 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.574 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.014 CHEMBL219497 | CHEMBL219497 | |
| 0.026 | 0.601 | 0.098 | CDK3/cyclin E inhibitor | 0.098 0.092 CHEMBL185 | CHEMBL185 | |
| 0.009 | 0.593 | 0.107 | MAP kinase kinase inhibitor | 0.106 0.088 CHEMBL185 0.107 0.088 CHEMBL219497 | CHEMBL219497 | |
| 0.003 | 0.592 | 0.025 | AMPA 3 receptor antagonist | 0.025 0.024 CHEMBL3544571 | CHEMBL3544571 | |
| 0.042 | 0.632 | 0.191 | Neurotensin receptor agonist | 0.142 0.123 CHEMBL185 0.163 0.074 CHEMBL3544570 0.191 0.04 CHEMBL3544571 | CHEMBL3544571 | |
| 0.016 | 0.61 | 0.179 | Hypolipemic | 0.179 0.11 CHEMBL3544570 | CHEMBL3544570 | |
| 0.004 | 0.6 | 0.062 | Neutrophil collagenase inhibitor | 0.062 0.048 CHEMBL3544571 | CHEMBL3544571 | |
| 0.02 | 0.616 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | 0.13 0.056 CHEMBL3544570 0.157 0.028 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.601 | 0.054 | Vascular adhesion protein 1 inhibitor | 0.043 0.022 CHEMBL219497 0.047 0.018 CHEMBL3544570 0.054 0.012 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.612 | 0.055 | Glutamate (mGluR4) antagonist | 0.055 0.017 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.604 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.035 0.018 CHEMBL185 | CHEMBL185 | |
| 0.008 | 0.611 | 0.096 | Carbonic anhydrase stimulant | 0.096 0.02 CHEMBL3544570 0.094 0.02 CHEMBL3544571 | CHEMBL3544570 | |
| 0.02 | 0.623 | 0.17 | Vanilloid agonist | 0.105 0.028 CHEMBL3544570 0.17 0.009 CHEMBL3544571 | CHEMBL3544571 | |
| 0.005 | 0.609 | 0.067 | Alpha 1 adrenoreceptor antagonist | 0.067 0.061 CHEMBL185 | CHEMBL185 | |
| 0.005 | 0.61 | 0.069 | Collagenase 3 inhibitor | 0.069 0.032 CHEMBL185 | CHEMBL185 | |
| 0.049 | 0.655 | 0.418 | GABA C receptor rho-3 antagonist | 0.418 0.054 CHEMBL185 0.358 0.081 CHEMBL219497 0.258 0.147 CHEMBL3544570 0.397 0.063 CHEMBL3544571 | CHEMBL185 | |
| 0.004 | 0.612 | 0.105 | NMDA receptor glycine site agonist | 0.105 0.014 CHEMBL3544570 0.094 0.019 CHEMBL3544571 | CHEMBL3544570 | |
| 0.006 | 0.615 | 0.112 | Acetylcholine agonist | 0.112 0.04 CHEMBL219497 | CHEMBL219497 | |
| 0.008 | 0.618 | 0.13 | NMDA receptor agonist | 0.13 0.011 CHEMBL3544570 0.125 0.012 CHEMBL3544571 | CHEMBL3544570 | |
| 0.06 | 0.671 | 0.384 | Tyrosine 3 hydroxylase inhibitor | 0.188 0.158 CHEMBL185 0.21 0.119 CHEMBL219497 0.296 0.035 CHEMBL3544570 0.384 0.01 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.614 | 0.047 | Free fatty acid receptor 1 agonist | 0.047 0.005 CHEMBL3544571 | CHEMBL3544571 | |
| 0.005 | 0.617 | 0.048 | AMPA 4 receptor antagonist | 0.048 0.017 CHEMBL3544571 | CHEMBL3544571 | |
| 0.009 | 0.624 | 0.049 | Glutamate (mGluR group III) antagonist | 0.049 0.022 CHEMBL3544571 | CHEMBL3544571 | |
| 0.006 | 0.623 | 0.085 | Phosphodiesterase III inhibitor | 0.08 0.035 CHEMBL185 0.085 0.032 CHEMBL219497 | CHEMBL219497 | |
| 0.008 | 0.631 | 0.209 | Phospholipase A2 inhibitor | 0.146 0.078 CHEMBL3544570 0.209 0.038 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.627 | 0.039 | Carboxypeptidase B inhibitor | 0.038 0.015 CHEMBL3544570 0.039 0.014 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.64 | 0.367 | GABA B receptor agonist | 0.138 0.005 CHEMBL3544570 0.367 0.002 CHEMBL3544571 | CHEMBL3544571 | |
| 0.006 | 0.635 | 0.032 | Melatonin receptor 1A agonist | 0.032 0.026 CHEMBL3544570 | CHEMBL3544570 | |
| 0.015 | 0.65 | 0.083 | Exportin-1 inhibitor | 0.066 0.052 CHEMBL185 0.083 0.021 CHEMBL219497 0.069 0.046 CHEMBL3544570 0.082 0.023 CHEMBL3544571 | CHEMBL219497 | |
| 0.017 | 0.652 | 0.143 | Nav1.2 sodium channel blocker | 0.143 0.062 CHEMBL219497 | CHEMBL219497 | |
| 0.004 | 0.639 | 0.031 | Dipeptidyl peptidase II inhibitor | 0.031 0.025 CHEMBL3544571 | CHEMBL3544571 | |
| 0.012 | 0.648 | 0.079 | Calcium-independent phospholipase A2 inhibitor | 0.063 0.003 CHEMBL3544570 0.079 0.002 CHEMBL3544571 | CHEMBL3544571 | |
| 0.032 | 0.669 | 0.254 | Gastrin inhibitor | 0.204 0.142 CHEMBL185 0.254 0.074 CHEMBL3544570 0.184 0.173 CHEMBL3544571 | CHEMBL3544570 | |
| 0.013 | 0.653 | 0.261 | Insulin sensitizer | 0.228 0.049 CHEMBL3544570 0.261 0.029 CHEMBL3544571 | CHEMBL3544571 | |
| 0.049 | 0.69 | 0.388 | 5 Hydroxytryptamine release inhibitor | 0.268 0.203 CHEMBL185 0.388 0.086 CHEMBL3544571 | CHEMBL3544571 | |
| 0.076 | 0.725 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.06 CHEMBL185 0.174 0.123 CHEMBL219497 0.192 0.077 CHEMBL3544571 | CHEMBL185 | |
| 0.017 | 0.668 | 0.125 | Nav1.3 sodium channel blocker | 0.102 0.095 CHEMBL185 0.125 0.069 CHEMBL219497 | CHEMBL219497 | |
| 0.002 | 0.654 | 0.036 | Retinoid X alpha receptor agonist | 0.036 0.023 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.656 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.016 CHEMBL3544571 | CHEMBL3544571 | |
| 0.011 | 0.671 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.046 CHEMBL185 | CHEMBL185 | |
| 0.005 | 0.666 | 0.043 | Carbonic anhydrase I stimulant | 0.043 0.021 CHEMBL3544570 0.033 0.031 CHEMBL3544571 | CHEMBL3544570 | |
| 0.024 | 0.686 | 0.134 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.131 CHEMBL185 | CHEMBL185 | |
| 0.011 | 0.676 | 0.644 | Chelator | 0.251 0.016 CHEMBL3544570 0.644 0.003 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.67 | 0.119 | Alpha 1b adrenoreceptor antagonist | 0.119 0.029 CHEMBL185 | CHEMBL185 | |
| 0.003 | 0.673 | 0.1 | Alpha 1d adrenoreceptor antagonist | 0.1 0.023 CHEMBL185 | CHEMBL185 | |
| 0.014 | 0.688 | 0.087 | Bromodomain-containing protein 2 inhibitor | 0.087 0.062 CHEMBL185 | CHEMBL185 | |
| 0.008 | 0.685 | 0.06 | I kappa B kinase 2 inhibitor | 0.06 0.047 CHEMBL219497 | CHEMBL219497 | |
| 0.004 | 0.683 | 0.094 | Epoxide hydrolase inhibitor | 0.094 0.029 CHEMBL3544570 | CHEMBL3544570 | |
| 0.003 | 0.684 | 0.05 | Integrin alphaVbeta3 antagonist | 0.05 0.005 CHEMBL219497 | CHEMBL219497 | |
| 0.006 | 0.69 | 0.137 | TRKB antagonist | 0.137 0.055 CHEMBL219497 | CHEMBL219497 | |
| 0.004 | 0.694 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.05 0.021 CHEMBL185 0.051 0.02 CHEMBL219497 | CHEMBL219497 | |
| 0.002 | 0.693 | 0.035 | Diamine oxidase inhibitor | 0.035 0.029 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.695 | 0.049 | Histamine H2 receptor agonist | 0.043 0.03 CHEMBL185 0.049 0.023 CHEMBL3544570 | CHEMBL3544570 | |
| 0.005 | 0.71 | 0.08 | Dipeptidyl peptidase inhibitor | 0.058 0.029 CHEMBL185 0.08 0.014 CHEMBL219497 | CHEMBL219497 | |
| 0.006 | 0.716 | 0.138 | Toll-Like receptor 7 antagonist | 0.138 0.008 CHEMBL219497 | CHEMBL219497 | |
| 0.002 | 0.713 | 0.062 | Glucagon receptor antagonist | 0.053 0.009 CHEMBL3544570 0.062 0.007 CHEMBL3544571 | CHEMBL3544571 | |
| 0.007 | 0.72 | 0.197 | Sphingosine 1-phosphate receptor 2 antagonist | 0.197 0.008 CHEMBL3544570 0.18 0.015 CHEMBL3544571 | CHEMBL3544570 | |
| 0.009 | 0.729 | 0.123 | Heat shock protein 90 alpha antagonist | 0.123 0.122 CHEMBL185 | CHEMBL185 | |
| 0.004 | 0.726 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.039 CHEMBL3544570 0.069 0.027 CHEMBL3544571 | CHEMBL3544571 | |
| 0.008 | 0.731 | 0.073 | Phosphodiesterase 7A inhibitor | 0.056 0.028 CHEMBL185 0.073 0.009 CHEMBL219497 | CHEMBL219497 | |
| 0.007 | 0.732 | 0.037 | Erythropoietin receptor agonist | 0.037 0.032 CHEMBL3544570 | CHEMBL3544570 | |
| 0.007 | 0.735 | 0.204 | GABA receptor agonist | 0.204 0.017 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.741 | 0.076 | Sphingosine 1-phosphate receptor 4 agonist | 0.076 0.04 CHEMBL3544571 | CHEMBL3544571 | |
| 0.013 | 0.755 | 0.05 | Carbonic anhydrase II stimulant | 0.05 0.04 CHEMBL3544570 0.048 0.045 CHEMBL3544571 | CHEMBL3544570 | |
| 0.004 | 0.746 | 0.157 | Inducible nitric-oxide synthase inhibitor | 0.125 0.023 CHEMBL3544570 0.157 0.015 CHEMBL3544571 | CHEMBL3544571 | |
| 0.008 | 0.753 | 0.113 | Caspase 3 inhibitor | 0.113 0.071 CHEMBL3544571 | CHEMBL3544571 | |
| 0.012 | 0.763 | 0.142 | Sphingosine 1-phosphate receptor 5 antagonist | 0.142 0.076 CHEMBL3544571 | CHEMBL3544571 | |
| 0.022 | 0.778 | 0.295 | Insulysin inhibitor | 0.19 0.173 CHEMBL185 0.253 0.093 CHEMBL3544570 0.295 0.062 CHEMBL3544571 | CHEMBL3544571 | |
| 0.005 | 0.77 | 0.039 | Glutamate (mGluR group III) agonist | 0.039 0.035 CHEMBL3544571 | CHEMBL3544571 | |
| 0.017 | 0.793 | 0.174 | Neuropeptide Y2 antagonist | 0.174 0.173 CHEMBL3544570 | CHEMBL3544570 | |
| 0.003 | 0.789 | 0.071 | TRPA1 antagonist | 0.055 0.05 CHEMBL185 0.071 0.031 CHEMBL219497 | CHEMBL219497 | |
| 0.014 | 0.804 | 0.057 | DNA helicase inhibitor | 0.057 0.033 CHEMBL3544571 | CHEMBL3544571 | |
| 0.027 | 0.817 | 0.09 | Folate antagonist | 0.09 0.088 CHEMBL3544571 | CHEMBL3544571 | |
| 0.01 | 0.801 | 0.069 | CXC chemokine 1 receptor antagonist | 0.062 0.02 CHEMBL3544570 0.069 0.014 CHEMBL3544571 | CHEMBL3544571 | |
| 0.002 | 0.798 | 0.034 | Epoxide hydrolase 2 inhibitor | 0.034 0.012 CHEMBL3544570 | CHEMBL3544570 | |
| 0.005 | 0.809 | 0.037 | Acetyl-CoA carboxylase inhibitor | 0.037 0.036 CHEMBL3544570 | CHEMBL3544570 | |
| 0.003 | 0.812 | 0.047 | Dipeptidyl peptidase I inhibitor | 0.047 0.009 CHEMBL219497 | CHEMBL219497 | |
| 0.004 | 0.83 | 0.086 | Phosphodiesterase VII inhibitor | 0.056 0.052 CHEMBL185 0.086 0.021 CHEMBL219497 | CHEMBL219497 | |
| 0.004 | 0.831 | 0.088 | NMDA 2B receptor antagonist | 0.088 0.018 CHEMBL219497 | CHEMBL219497 | |
| 0.003 | 0.831 | 0.099 | NMDA receptor antagonist | 0.099 0.048 CHEMBL3544571 | CHEMBL3544571 | |
| 0.005 | 0.84 | 0.064 | Leukotriene synthesis inhibitor | 0.064 0.049 CHEMBL3544570 | CHEMBL3544570 | |
| 0.001 | 0.84 | 0.039 | Endothelial nitric-oxide synthase inhibitor | 0.039 0.014 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.844 | 0.337 | Kinesin antagonist | 0.145 0.005 CHEMBL219497 0.082 0.01 CHEMBL3544570 0.337 0.003 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.844 | 0.337 | Kinesin-like protein 1 inhibitor | 0.145 0.005 CHEMBL219497 0.082 0.01 CHEMBL3544570 0.337 0.003 CHEMBL3544571 | CHEMBL3544571 | |
| 0.004 | 0.849 | 0.037 | Integrin alpha5beta1 antagonist | 0.037 0.035 CHEMBL3544570 | CHEMBL3544570 | |
| 0.002 | 0.858 | 0.034 | Dipeptidyl peptidase IX inhibitor | 0.034 0.005 CHEMBL219497 | CHEMBL219497 | |
| 0.007 | 0.863 | 0.164 | 5 Hydroxytryptamine 1B agonist | 0.063 0.023 CHEMBL3544570 0.164 0.004 CHEMBL3544571 | CHEMBL3544571 | |
| 0.013 | 0.871 | 0.088 | Phosphodiesterase 7B inhibitor | 0.088 0.073 CHEMBL185 | CHEMBL185 | |
| 0.002 | 0.865 | 0.055 | Complement C3a chemotactic receptor antagonist | 0.055 0.024 CHEMBL3544570 0.049 0.027 CHEMBL3544571 | CHEMBL3544570 | |
| 0.003 | 0.872 | 0.142 | Nitric-oxide synthase inhibitor | 0.101 0.059 CHEMBL3544570 0.142 0.026 CHEMBL3544571 | CHEMBL3544571 | |
| 0.003 | 0.876 | 0.052 | Raf kinase B inhibitor | 0.052 0.048 CHEMBL185 | CHEMBL185 | |
| 0.002 | 0.876 | 0.019 | Dipeptidyl peptidase VIII inhibitor | 0.019 0.007 CHEMBL219497 | CHEMBL219497 | |
| 0.004 | 0.881 | 0.156 | Neuropeptide Y1 antagonist | 0.156 0.056 CHEMBL3544570 | CHEMBL3544570 | |
| 0.004 | 0.906 | 0.044 | VCAM-1 antagonist | 0.044 0.015 CHEMBL3544570 0.043 0.017 CHEMBL3544571 | CHEMBL3544570 | |
| 0.004 | 0.907 | 0.044 | VCAM antagonist | 0.044 0.015 CHEMBL3544570 0.043 0.017 CHEMBL3544571 | CHEMBL3544570 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |